Conmed CORP Form 4 insider transactions

Curt R. Hartman, President and CEO of CONMED Corp, exercised stock appreciation rights and disposed of shares on November 7, 2024.

Hollie K. Foust, General Counsel & Corp Sec of CONMED Corp, reports the acquisition of 8,000 Restricted Stock Units (RSUs) on November 4, 2024, according to a Form 4 filing with the SEC.

Todd W. Garner, Executive Vice President & CFO of CONMED Corp, reports the acquisition of 22,727 Restricted Stock Units (RSUs) on November 1, 2024, according to a Form 4 filing with the SEC.

Director Charles Farkas exercised stock appreciation rights and disposed of shares of CONMED Corp on September 5, 2024.

Edward A. Clifford, VP Global Manufacturing at Conmed Corp, reports the settlement of vested restricted stock units and subsequent disposition of shares to cover taxes.

Stanley W. Peters III, President AS and AET of CONMED Corp, exercised stock options and sold shares on June 14, 2024.

Director Brian Concannon reports the acquisition and disposal of Conmed Corp stock and derivative securities.

Director Jerome J. Lande reports the exercise of stock options and adjustments to beneficial ownership of CONMED Corp shares.

Director John L. Workman reports acquisition and disposition of CONMED Corp stock and derivative securities.

Director David M. Bronson reports transactions involving Conmed Corp stock, including the acquisition of shares through restricted stock units and options.

Director Charles Farkas reports acquisition and disposal of CONMED Corp stock and derivative securities.

Director Martha Goldberg Aronson reports acquisition and disposal of CONMED Corp stock and derivative securities.

Director LaVerne H. Council reports acquisition and disposal of Conmed Corp stock and derivative securities.

Director Barbara J. Schwarzentraub reports transactions involving CONMED Corp stock, including the acquisition and disposal of shares and derivative securities.

Director David M. Bronson purchased 1,350 shares of CONMED Corp stock at $72.09 per share on May 13, 2024, according to a recent SEC filing.

Barbara J. Schwarzentraub, a director at CONMED Corp, reported purchasing 1,442 shares of common stock at an average price of $69.26 on May 8, 2024.

Director Martha Goldberg Aronson purchased 2,000 shares of CONMED Corp common stock at an average price of $70.98 on May 6, 2024.

CONMED Corp's Chief Operating Officer, Pat Beyer, recently purchased 3,000 shares of the company's common stock at an average price of $68.30 per share.

Pat Beyer, Chief Operating Officer of CONMED Corp, reports the acquisition of 20,060 stock options on April 24, 2024, under the company's 2018 Long-Term Incentive Plan.

Executive Vice President & CFO of CONMED Corp, Todd W. Garner, reports the acquisition of 227 shares of common stock at $76.08 per share on March 28, 2024.

Heather L. Cohen, EVP & Chief HR & Legal Officer of CONMED Corp, recently acquired 227 shares of common stock at a price of $76.08 per share.

EVP & Chief HR & Legal Officer Heather L. Cohen exercised stock options and disposed of shares of CONMED Corp on March 8, 2024.

Brent Lalomia, Vice President of QA and RA at Conmed Corp, reports the vesting and subsequent disposal of shares to cover tax obligations.

Peter K. Shagory, EVP at CONMED Corp, reports acquisition of 18,988 stock options on March 1, 2024.

Stanley W. Peters III, President AS and AET of CONMED Corp, reports the acquisition of 33,508 stock options on March 1, 2024.

Johonna Pelletier, Treasurer and VP, Tax of CONMED Corp, was granted 8,000 stock options on March 1, 2024, according to a Form 4 filing with the SEC.

Brent Lalomia, Vice President of QA and RA at CONMED Corp, acquired 18,988 stock options on March 1, 2024, under the company's 2018 Long-Term Incentive Plan.

CONMED Corp's CEO, Curt Hartman, was granted 79,154 stock options on March 1, 2024, under the company's 2018 Long-Term Incentive Plan.

Todd W. Garner, Executive Vice President & CFO of CONMED Corp, was granted 44,677 stock options on March 1, 2024, under the company's 2018 Long-Term Incentive Plan.

John D. Ferrell, Executive Vice President HR of CONMED Corp, was granted 11,250 stock options on March 1, 2024, under the company's 2018 Long-Term Incentive Plan.